期刊文献+

平目颗粒治疗非活动期Graves眼病阳气亏虚、痰瘀阻滞证的临床观察 被引量:16

Clinical Observation on Treatment of Non-active Graves' Ophthalmopathy with Syndrome of Yang-Qi Deficiency and Phlegm-Blood Stagnation by Pingmu Granule
下载PDF
导出
摘要 目的:观察平目颗粒治疗非活动期Graves眼病患者阳气亏虚、痰瘀阻滞证的临床疗效。方法:将来自三个分中心90例非活动期Graves眼病患者,按照区组随机、双盲、对照原则分为试验组和对照组,试验组予平目颗粒,对照组予平目颗粒模拟剂,疗程24周,分别观察两组治疗前后突眼度,中医证候改善情况(中医证候积分)及有效率,游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素(TSH)的变化情况,安全性指标血常规、尿常规、大便常规、肝肾功能及心电图,观察可能出现的不良反应。结果:治疗后两组突眼度总有效率比较,试验组为81.4%,对照组17.1%,试验组较对照组明显降低患者的突眼度(P<0.01)。试验组中医证侯疗效总有效率为88.37%,对照组总有效率为31.71%,试验组中医证侯改善明显优于对照组(P<0.01)。治疗前后两组甲状腺功能比较,差异无统计学意义。治疗后两组安全性指标检查均正常。结论:与对照组比较,平目颗粒可有效降低非活动期Graves眼病阳气亏虚、痰瘀阻滞证患者的突眼度,改善其临床中医证候,具有良好的临床疗效和安全性。 Objective:To observe the clinical efficacy of Pingmu Granule in treating non -active Graves Ophthalmopathy with syndrome of yang- qi deficiency and phlegm- blood stagnation. Methods :90 cases of patients with non- active Graves Ophthalmopathy were collected and divided into treatment group and control group according to the methods of a multi -center, block randomization, double -blind, contras methodt. The treatment group was treated with Pingmu Granule and the control one was treated with the simulation drug and the course of treatment was 24 weeks. The clinical curative effect and Chinese medicine symptom complex score were evaluated. The degrees of exophthalmus, the level of free triiodothyronine ( FT3 ), free thyroxine ( PlOd ), and thyroid strmulating hormone (TSH) were detected. Blood routine, urine routine, stool routine, the function of liver and kindney, and electrocardiograph were monitored, and the adverse reactions were examined. Results :The total effective rate of the treatment group and control group was 81.4% and 17.1% respectively, and the Chinese medicine symptom complex score of treatment group and control group was 88.37 % and 31.71% , respectively. Compared to control group, the treatment group significantly reduced the degree of exophthalmus and improved Chinese medicine symptom of patients with non -active Graves Ophthalmopathy (P 〈0.01 ). There was no differ- ence in the thyroid function test such as FT3, FF4 and TSH between before and after treatment. The security indicators are also normal after treatment. Conclusions : Pingmu Granule is an effective and safe drug to treat the non - active Graves disease with syndrome of yang- qi deficiency and phlegm- blood stagnation.
出处 《中华中医药学刊》 CAS 2014年第9期2124-2127,共4页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金项目(81072793,81373617) 国家中医临床研究基地龙医团队项目(LYTD-10) 上海市教委科研创新重点资助项目(11ZZ114)
关键词 平目颗粒 非活动期 Graves眼病 温阳益气、化痰祛瘀 Pingmu Granule non - active Graves Ophthalmopathy warming - yang and benefiting qi dissipating phlegm and removing blood stasis
  • 相关文献

参考文献11

二级参考文献34

  • 1岳式君,单忠艳,旷劲松,韩军星.大剂量激素冲击疗法治疗浸润性突眼[J].中国医科大学学报,1996,25(3):316-317. 被引量:14
  • 2Terwee C,Wakelkamp L,Tan S, et al. [J]. Eur J Endocrlnol, 2002,146 ( 6 ) :751-757.
  • 3Bednarczuk T, Hiromatsu Y, Fukutani T, et al.[J]. Eur J Endocrinol,2003,148( 1 ) :13-18.
  • 4Bahn RS. [J]. Endocrinol Metab Clin North Am,2000,29 ( 2 ) : 287-296.
  • 5Human PK. [J]. Cell Mol Life Sei, 2001,58:1301-1322.
  • 6Heufelder AE. [J]. Endocr Metab Disorder,2000,1 : 87-95.
  • 7Noh JY,Hamada N, Inoue Y,et al. [J] Thyroid,2000,9:809-813.
  • 8Hegedius L, Brix TH, Vestergaard P. [J]. J Endocrionl Invest, 2004,27 ( 3 ) : 265-271.
  • 9Bartalena L,Pinchera A, Marcocci C. [ J]. Endocrine Rev ,2000,21 ( 2 ) : 168-199.
  • 10Bartalena L, Marcocci C, Maria-Laura T. et al.[J]. Thyroid, 2002,12 ( 3 ) : 245-250.

共引文献166

同被引文献164

引证文献16

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部